ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
Public ClinicalTrials.gov record NCT02126670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02126670
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Promius Pharma, LLC
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- ACT01 Drug
- Comp01 Drug
- Comp02 Drug
- Comp03 Drug
- Comp04 Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Aug 31, 2014
- Completion
- Aug 31, 2014
- Last update posted
- Feb 21, 2016
2014
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Dermatology Specialists Research, LLC | Louisville | Kentucky | 40202 | — |
| Dermatology Consulting Services; Zoe Diana Draelos, MD | High Point | North Carolina | 27262 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02126670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02126670 live on ClinicalTrials.gov.